Product Code: ETC8850581 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Respiratory Disease Vaccine Market in the Philippines includes vaccines aimed at preventing respiratory diseases such as pneumonia, influenza, and COVID-19. The market is witnessing growth due to the rising burden of respiratory infections and the governments vaccination programs to reduce the incidence of these diseases. Increasing public health awareness and the drive for herd immunity are key factors supporting this market. Moreover, international collaborations and vaccine production in the country play a significant role in market expansion.
The respiratory disease vaccine market in the Philippines is experiencing increased attention, particularly for vaccines against pneumonia, influenza, and COVID-19. Government immunization programs and heightened awareness of vaccine-preventable respiratory diseases are key growth drivers. Expansion of vaccine coverage across age groups is expected to sustain market growth.
Vaccine adoption is slowed by logistical challenges in cold chain management, vaccine hesitancy, and inconsistent government funding for mass immunization programs. Additionally, fragmented healthcare infrastructure in rural regions reduces outreach and timely administration of vaccines against respiratory diseases.
The respiratory disease vaccine market in the Philippines is growing due to the increased focus on vaccination programs, particularly for diseases like pneumonia, influenza, and COVID-19. With government support for immunization programs and a rising awareness of the importance of respiratory health, there are opportunities for pharmaceutical companies to expand their vaccine offerings in the local market. Investment in research, development, and distribution could yield significant returns in this high-demand sector.
The government of the Philippines has been actively involved in regulating and promoting vaccines, including those for respiratory diseases such as influenza and pneumonia. Through the Department of Health (DOH) and the Philippine Food and Drug Administration (FDA), the government ensures that vaccines meet safety and efficacy standards. In response to the growing threat of respiratory diseases, particularly COVID-19, the government has implemented national vaccination programs, which increase the demand for respiratory disease vaccines. These initiatives support the growth of the vaccine market in the country.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Respiratory Disease Vaccine Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Respiratory Disease Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Respiratory Disease Vaccine Market - Industry Life Cycle |
3.4 Philippines Respiratory Disease Vaccine Market - Porter's Five Forces |
3.5 Philippines Respiratory Disease Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Philippines Respiratory Disease Vaccine Market Revenues & Volume Share, By Vaccine, 2021 & 2031F |
3.7 Philippines Respiratory Disease Vaccine Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.8 Philippines Respiratory Disease Vaccine Market Revenues & Volume Share, By Age, 2021 & 2031F |
3.9 Philippines Respiratory Disease Vaccine Market Revenues & Volume Share, By End user, 2021 & 2031F |
3.10 Philippines Respiratory Disease Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Philippines Respiratory Disease Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Respiratory Disease Vaccine Market Trends |
6 Philippines Respiratory Disease Vaccine Market, By Types |
6.1 Philippines Respiratory Disease Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Respiratory Disease Vaccine Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Philippines Respiratory Disease Vaccine Market Revenues & Volume, By Viral Vaccine, 2021- 2031F |
6.1.4 Philippines Respiratory Disease Vaccine Market Revenues & Volume, By Bacterial Vaccine, 2021- 2031F |
6.1.5 Philippines Respiratory Disease Vaccine Market Revenues & Volume, By Combination Vaccine, 2021- 2031F |
6.2 Philippines Respiratory Disease Vaccine Market, By Vaccine |
6.2.1 Overview and Analysis |
6.2.2 Philippines Respiratory Disease Vaccine Market Revenues & Volume, By MMR, 2021- 2031F |
6.2.3 Philippines Respiratory Disease Vaccine Market Revenues & Volume, By PPSV23, 2021- 2031F |
6.2.4 Philippines Respiratory Disease Vaccine Market Revenues & Volume, By DTaP, 2021- 2031F |
6.2.5 Philippines Respiratory Disease Vaccine Market Revenues & Volume, By Respiratory Syncytial Virus (RSV), 2021- 2031F |
6.2.6 Philippines Respiratory Disease Vaccine Market Revenues & Volume, By Haemophilus Influenzae Type B (Hib), 2021- 2031F |
6.3 Philippines Respiratory Disease Vaccine Market, By Disease Type |
6.3.1 Overview and Analysis |
6.3.2 Philippines Respiratory Disease Vaccine Market Revenues & Volume, By Tuberculosis, 2021- 2031F |
6.3.3 Philippines Respiratory Disease Vaccine Market Revenues & Volume, By Pertussis, 2021- 2031F |
6.3.4 Philippines Respiratory Disease Vaccine Market Revenues & Volume, By Influenza Virus, 2021- 2031F |
6.3.5 Philippines Respiratory Disease Vaccine Market Revenues & Volume, By Streptococcus Pneumoniae (Pneumonia), 2021- 2031F |
6.3.6 Philippines Respiratory Disease Vaccine Market Revenues & Volume, By Chronic Obstructive Pulmonary Disease (COPD), 2021- 2031F |
6.3.7 Philippines Respiratory Disease Vaccine Market Revenues & Volume, By Diphtheria, 2021- 2031F |
6.4 Philippines Respiratory Disease Vaccine Market, By Age |
6.4.1 Overview and Analysis |
6.4.2 Philippines Respiratory Disease Vaccine Market Revenues & Volume, By Infant, 2021- 2031F |
6.4.3 Philippines Respiratory Disease Vaccine Market Revenues & Volume, By Adolescent, 2021- 2031F |
6.4.4 Philippines Respiratory Disease Vaccine Market Revenues & Volume, By Adult, 2021- 2031F |
6.5 Philippines Respiratory Disease Vaccine Market, By End user |
6.5.1 Overview and Analysis |
6.5.2 Philippines Respiratory Disease Vaccine Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Philippines Respiratory Disease Vaccine Market Revenues & Volume, By Clinics, 2021- 2031F |
6.5.4 Philippines Respiratory Disease Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Philippines Respiratory Disease Vaccine Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Philippines Respiratory Disease Vaccine Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Philippines Respiratory Disease Vaccine Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Philippines Respiratory Disease Vaccine Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Philippines Respiratory Disease Vaccine Market Import-Export Trade Statistics |
7.1 Philippines Respiratory Disease Vaccine Market Export to Major Countries |
7.2 Philippines Respiratory Disease Vaccine Market Imports from Major Countries |
8 Philippines Respiratory Disease Vaccine Market Key Performance Indicators |
9 Philippines Respiratory Disease Vaccine Market - Opportunity Assessment |
9.1 Philippines Respiratory Disease Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Philippines Respiratory Disease Vaccine Market Opportunity Assessment, By Vaccine, 2021 & 2031F |
9.3 Philippines Respiratory Disease Vaccine Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.4 Philippines Respiratory Disease Vaccine Market Opportunity Assessment, By Age, 2021 & 2031F |
9.5 Philippines Respiratory Disease Vaccine Market Opportunity Assessment, By End user, 2021 & 2031F |
9.6 Philippines Respiratory Disease Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Philippines Respiratory Disease Vaccine Market - Competitive Landscape |
10.1 Philippines Respiratory Disease Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Philippines Respiratory Disease Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |